Latest From Biotech Now

WSJ: A Piece of the Immunotherapy Puzzle Solved

Just two weeks ago, the New York Times published a series of articles deeming immunotherapy as the future for cancer advances and new life-saving treatments – even though it’s not entirely clear why only some patients have success with the treatments. This week, the Wall Street Journal joined the immunotherapy conversation by highlighting two researchers who may have unlocked part of the mystery as to why only some patients benefit from immunotherapy. When Dr. Michael Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Vote for Your Favorite Innovator – BIF’s Buzz of BIO Voting Now Open!

Buzz of BIO contest, BIO Investor Forum

During the past week nominations were accepted for this year’s Buzz of BIO contest sponsored by the 2016 BIO Investor Forum (BIF)—October 18-19 at the Westin St. Francis Hotel in San Francisco. Ten innovative biotech companies were nominated in each of two categories—Early Stage Entrepreneurs and Late Stage Leaders. Now it’s time to vote. Cast your ballot for a company in each category. Winners will receive complimentary conference registration, a Company Presentation and promotion to industry leaders including Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Big Things Are Happening within Iowa’s Biotech Industry


Over the last decade Iowa has built a specialized and diverse bioscience industry. In particular, it has become a national leader in the agricultural biosciences where the state accounts for 10 percent of U.S. employment. As this article from The Scientist demonstrates, Iowa is no longer just an Ag bioscience hub, its significant investments in biopharma R&D are paying off and demonstrating the value of bioscience innovation in growing jobs and improving quality of life.

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,

Despite Latest Report, ICER Still Limits Patient Input and Maintains Strong Ties To Insurers


After months of criticism, including some from BIO, the Institute for Clinical and Economic Review (ICER) released a document that tries to address many of the legitimate and persistent concerns that have been raised. We appreciate that ICER is taking such criticism more seriously, and recently opened up its methodology to more public comment.  However, after reviewing the document, it remains clear to us that ICER still doesn’t quite get why so many organizations, including Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , ,

What We’re Reading at GMO Answers


Each month, GMO Answers compiles a few of our favorite news stories into one post on the GMO Answers website.  This post can cover a wide variety of topics related to agriculture and biotechnology, ranging from global hunger and climate change, to genetically modified insulin and the marketing of foods. This month’s post uses the Zika outbreak in Brazil as a jumping off point, and finishes up with a nice profile of Dr. Calestous Juma Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,